Listen "What Companies should know about PMCs and Biocidal Products"
Episode Synopsis
🎙️ New Podcast Episode: Navigating the Transition from PMCs to Biocides In our latest episode, we delve into the evolving regulatory landscape surrounding Presidi Medico Chirurgici (PMCs) and their transition to biocidal products within the European Union. This shift, driven by Directive 98/8/EC, aims to harmonize standards across member states, ensuring enhanced safety and efficacy of products such as disinfectants, insecticides, and repellents.The directive introduces a comprehensive evaluation of active substances, categorizing biocidal products into 23 distinct types and necessitating rigorous assessments, including toxicological and ecotoxicological studies. This transformation presents significant challenges for companies, especially those navigating the complexities of dossier preparation and compliance during the transitional phaseDi Renzo Regulatory Affairs offers expert guidance to companies, assisting in feasibility studies, regulatory intelligence, and the preparation of comprehensive dossiers to facilitate a smooth transition from PMCs to biocides.Tune in to gain valuable insights into adapting to these regulatory changes and ensuring your products meet the new European standards. 🔗 Read the full article
More episodes of the podcast Regulatory Affairs & Life Science
Pharmacovigilance Goes Social
12/09/2025
Classification of medical devices in Italy
21/08/2025
Is our software a Medical Device?
02/07/2025
Labelling pharmaceutical sectors
10/06/2025
Are our cosmetics labels compliant
30/05/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.